These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Metrizamide--CSF contrast medium. Analysis of clinical application in 215 patients.
    Author: Sackett JF, Strother CM, Quaglieri CE, Javid MJ, Levin AB, Duff TA.
    Journal: Radiology; 1977 Jun; 123(3):779-82. PubMed ID: 860047.
    Abstract:
    Two-hundred-fifteen patients were evaluated with metrizamide, a new water-soluble contrast agent for use in the subarachnoid spaces. Side effects were reported in 67% of these; 39% were moderate or severe. Cervical injections monitored by fluoroscopy provide the most precise positioning of the medium. The benefits of metrizamide use outweigh its risk.
    [Abstract] [Full Text] [Related] [New Search]